Barclays PLC Vaxart, Inc. Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.71 - $1.25 $21,558 - $37,955	30,364 Added 87.95%	64,889 $49,000
Q4 2022 Feb 13, 2023	SELL	$0.75 - $2.24 $466,194 - $1.39 Million	-621,592 Reduced 94.74%	34,525 $33,000
Q3 2022 Nov 03, 2022	BUY	$2.09 - $4.5 $1.35 Million - $2.91 Million	646,836 Added 6969.46%	656,117 $1.43 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $30,153 - $58,967	-11,168 Reduced 54.61%	9,281 $33,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $549,583 - $850,637	-128,108 Reduced 86.23%	20,449 $103,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $562,817 - $776,434	97,542 Added 191.2%	148,557 $931,000
Q3 2021 Nov 09, 2021	BUY	$6.67 - $9.8 $175,834 - $258,347	26,362 Added 106.93%	51,015 $407,000
Q2 2021 Aug 13, 2021	SELL	$5.06 - $10.78 $101,675 - $216,613	-20,094 Reduced 44.91%	24,653 $185,000
Q1 2021 May 13, 2021	SELL	$5.64 - $23.33 $744,310 - $3.08 Million	-131,970 Reduced 74.68%	44,747 $271,000
Q4 2020 Feb 11, 2021	BUY	$3.5 - $7.98 $140,066 - $319,351	40,019 Added 29.28%	176,717 $1.01 Million
Q3 2020 Nov 12, 2020	SELL	$4.78 - $16.97 $2,413 - $8,569	-505 Reduced 0.37%	136,698 $909,000
Q2 2020 Aug 12, 2020	BUY	$1.68 - $8.85 $230,501 - $1.21 Million	137,203 New	137,203 $1.22 Million

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.